TrialBMC cancer2017

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study.

Ruihua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.